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Abstract: Background: The World Health Organization recommends that host countries ensure
appropriate vaccinations to refugees, asylum seekers and migrants. However, information on
vaccination strategies targeting migrants in host countries is limited. Methods: In 2015–2016 we
carried out a survey among national experts from governmental bodies of 15 non-EU countries of the
Mediterranean and Black Sea in order to document and share national vaccination strategies targeting
newly arrived migrants. Results: Four countries reported having regulations/procedures supporting
the immunization of migrants at national level, one at sub-national level and three only targeting
specific population groups. Eight countries offer migrant children all the vaccinations included in
their national immunization schedule; three provide only selected vaccinations, mainly measles and
polio vaccines. Ten and eight countries also offer selected vaccinations to adolescents and adults
respectively. Eight countries provide vaccinations at the community level; seven give priority vaccines
in holding centres or at entry sites. Data on administered vaccines are recorded in immunization
registries in nine countries. Conclusions: Although differing among countries, indications for
immunizing migrants are in place in most of them. However, we cannot infer from our findings
whether those strategies are currently functioning and whether barriers to their implementation are
being faced. Further studies focusing on these aspects are needed to develop concrete and targeted
recommendations for action. Since migrants are moving across countries, development of on-line
registries and cooperation between countries could allow keeping track of administered vaccines in
order to appropriately plan immunization series and avoid unnecessary vaccinations.
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1. Introduction
The World Health Organization (WHO) states that there is no systematic association between
migration and the importation of infectious diseases. However, conditions that migrants face during
their exhausting journeys, such as lack of sufficient water, and inadequate shelter and sanitation,
increase the risk of acquiring communicable diseases [1]. In addition, crowded settings such as
holding centres face an increased risk of outbreaks due to diseases such as measles, influenza,
varicella and meningococcal disease. This risk depends on the length of stay and on concurrent
sanitary conditions [2–6].
Unfortunately, despite the widespread availability of vaccines, misconceptions about vaccines and,
consequently, vaccination hesitancy are globally increasing in the general population [7–9]. Many host
countries have sub-optimal vaccination coverage rates with, in some cases, decreasing trends [10].
This is also the case for consolidated immunizations programmes like poliomyelitis vaccination. For
example, in Italy vaccination coverage among children has been decreasing since 2012. In 2015,
the vaccination coverage rate for poliomyelitis in children at 24 months of age in this country
dropped below 95% [11]. This comes at a time when the WHO European Region is at risk for
a poliomyelitis outbreak. The Regional Certification Commission for Poliomyelitis Eradication has
repeatedly identified Bosnia and Herzegovina, Romania and Ukraine as at high risk for transmission
in the event of wild poliovirus importation [12]. An outbreak of circulating vaccine-derived poliovirus
occurred in Ukraine in September 2015 [13]. Also, although targeted for elimination, in 2015 WHO
counted 30,762 measles cases in the European Region (nearly doubled in comparison to the previous
year) [14] and measles outbreaks continue to occur in many countries of the Region independently of
refugee and migrant population movement [12,14], confirming that pockets of susceptible individuals
are still present in recipients countries.
Decreasing immunization coverage combined with access barriers to immunization in countries
of transit and destination could hypothetically lead to a scenario where rapid inflows of large
numbers of unvaccinated people could increase existing immunity gaps. It is very hard to infer the
occurrence of measles or other vaccine preventable diseases (VPD) among migrants in Europe due to
the incompleteness of surveillance in relation to migrant health [6,15]. However, outbreaks of measles
and other VPDs have been documented in migrant settings within destination/transit countries of
Mediterranean migration routes [1,16–19]. In European countries, evidence of low seroprevalence rates
for several VPDs among high risk migrant groups and refugee children [20,21] and of lower vaccination
coverage among regular migrant populations compared with local populations [22] have also been
documented. This combined evidence suggests that mobile populations across the Mediterranean
migration routes may be vulnerable to VPDs as a result of low vaccination coverage in their countries
of origin and/or poor access to immunization in countries of transit/destination.
For this reason, in 2015 WHO-UNHCR-UNICEF jointly stated that refugees and asylum seekers
should have non-discriminatory, equitable access to vaccination, irrespective of their legal status and
regardless of their country of origin [12].
While population movement across the Mediterranean Basin has historical origins, in the last five
years migration flows across the Mediterranean Region have increased [23,24]. In 2016, according to
the European Agency for the Management of Operational Cooperation at the External Borders of the
Member States of the European Union (Frontex), migration routes across non- European Union (EU)
countries of the Mediterranean and Black Sea accounted for 487,717 irregular crossings to the EU (98%
of all irregular sea crossings to the EU) [25].
An increasing number of incoming migrants, with different migration statuses and diverse health
needs, is challenging public health authorities in countries within the Mediterranean migratory system
to ensure equitable access to disease prevention and control services, including for vaccine preventable
diseases. This concern, initially mainly of countries of destination, is becoming broader as countries
on both sides of the Mediterranean basin, traditionally of transit, are becoming long term or final
destinations for a growing number of migrants [26,27]. Formal and/or informal barriers to services
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could be hindering this access. Evidence from a cross-sectional study conducted in 2009 among
22 countries bordering the Mediterranean (EU and non EU) [28] has shown that, although eligibility
of migrants to immunization services offered as part of national immunization programs is almost
universal, informal barriers to immunization services (e.g., language, information and cultural barriers)
are a widespread issue.
Current recommendations by WHO-UNHCR-UNICEF [12] state that refugees, asylum seekers
and migrants should be vaccinated without necessary delay in the European region according to
the immunization schedule of the host countries. However, since access to a full immunization
schedule through follow up vaccinations is difficult to ensure while people are on the move,
measles/mumps/rubella (MMR) and polio vaccines should be prioritized.
This general policy needs implementation strategies adapted at country level to meet the
challenges and opportunities of each context. Furthermore, national strategies need to be shaped
into procedures that involve deliberate actions to achieve the goals set out in the strategy
and into regulations that imply an organization setting out the rules and monitoring their
implementation [29,30]. Therefore, existence of regulations, procedures and national strategic and
implementation plans indicates that a general policy has been translated at national level.
Information on immunization strategies targeting newly arrived migrants in all countries
bordering the Southern Mediterranean and Black Sea is not readily available. Following initial
actions carried out during the EpiSouth [31,32] and MedPremier (Preparedness in the Mediterranean
Region) [27] projects, in 2015–2016 the “VACcination PROgrammes in the MEDiterranean area”
(ProVacMed) Project [33] was implemented to enhance and share the knowledge on the control
of VPDs in the Mediterranean Area and Black Sea countries. In this project, existing strategies for
immunization of newly arrived migrants in non-EU countries of this Region were documented in
order to address this information gap and promote the sharing of information and experiences.
The ProVacMed study [33], as the other projects mentioned above [27,28,31,32], was coordinated
by the Italian Public Health Institute (Istituto Superiore di Sanità) that conducted the survey and
promoted interactions among the experts of the Network.
2. Materials and Methods
The EpiSouth and EpiSouth Plus projects [31,32] established a Network for the control of
cross-border health threats in the Mediterranean Basin and Middle East that involved officially
appointed experts in communicable diseases (Focal Points) in charge of surveillance and control
policies in the Ministries of Health or Public Health Institutions. Seventeen non-EU countries were
involved: Albania, Algeria, Bosnia & Herzegovina, Egypt, Israel, Jordan, Kosovo (designation without
prejudice to positions on status, in line with UNSC 1244 and the ICJ Opinion on the Kosovo declaration
of independence), Lebanon, Libya, Montenegro, Morocco, Palestine, Republic of Macedonia-FYROM,
Serbia, Syria, Tunisia and Turkey.
At the end of EpiSouth Plus Project (2014), the Network identified further priorities to
address [27,34] and expanded to also include four countries of Black Sea region (Armenia, Georgia,
Moldavia and Ukraine). Since then the Network was known as “Network for the control of cross-border
health threats in the Mediterranean Basin and Black Sea”.
While working on these new priorities, the need of the “ProVacMed” study was identified and
discussed with the Focal Points (FPs) during the Network Meeting on the 28–29 May 2015 [35].
Each country of the Network was invited to participate in the study and each FP was asked to identify,
within their institutions, experts directly involved in the monitoring and evaluation of national
immunization programs and/or migrant health in their country. Therefore, all appointed contact
persons were national experts in the field of vaccination and/or migrant health in the Ministries of
Health or Public Health Institutions of their countries.
Between February 2015 and August 2016 we carried out a cross-sectional survey among the
defined contact persons for the ProVacMed project. The aim of the study was to explore the existence
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of national regulations, procedures and implementation strategies supporting immunisation of newly
arrived migrants in non-EU countries of the Mediterranean Basin and Middle East and Black Sea.
As reported in previous studies [27,36], we defined newly arriving migrants as persons, other than
travellers or tourists, who had arrived in the previous year (less than 12 months) to a country other
than their usual residence.
To collect this information, we developed a questionnaire (in Excel format) addressing:
(i) if regulations/procedures supporting immunization of newly arrived migrants exist in
participating countries (no, yes at national level, yes only in some areas, other);
(ii) whether the countries verify migrants’ immunisation status before offering vaccinations (no, yes,
only for certain population groups, other);
(iii) how immunization status is verified (anamnesis evaluation, immunization card verification,
laboratory tests only if vaccination status is unknown, laboratory tests independently of
vaccination status) for each VPD;
(iv) which vaccinations (all vaccinations included in the NIP or specific vaccines) are offered to certain
target age groups, defined as children (≤10 years), adolescents (11–18 years), adults (>18 years),
and/or specific population groups (to be described by the focal point as open text);
(v) what are the sites for vaccination delivery to newly arrived migrants: entry level (e.g., borders,
points of entry); holding level (e.g., migration centres/camps); community level (vaccination after
arrival and partial integration to the community in the receiving country: e.g., in the primary
health care centres or vaccination services) for each vaccine;
(vi) whether countries record information on administered vaccines (no, in individual vaccination
cards, in electronic/paper registries).
For questions (iii), (iv) and (v) an exhaustive list of vaccines was proposed and respondents were
asked to provide the information required for each vaccine.
In December 2015, in order to verify if the questionnaire was clear, understandable and easy to
fill, it was piloted in two countries and modified accordingly.
In January 2016, the final version of the questionnaire was electronically sent to the expert
contact persons, who coordinated the collection of information for the questionnaire in their country,
also involving other national experts when appropriate. Those who did not reply to the questionnaire
after the initial contact were reminded by email or by phone. Data collection was completed in
May 2016.
We carried out a descriptive analysis of collected information. We performed a frequency analysis
for all the categorical variables collected and summarized the proportions of responses.
3. Results
Among the 21 non-EU countries involved in the Network for the control of cross-border health
threats in the Mediterranean Basin and Black Sea, the following 18 identified an expert working in
the vaccination and/or migrant health fields to involve in the ProVacMed study: Albania, Algeria,
Armenia, Bosnia & Herzegovina, Egypt, Georgia, Israel, Jordan, Kosovo, Lebanon, Libya, Moldavia,
Montenegro, Palestine, Republic of Macedonia-FYROM, Serbia, Tunisia, and Ukraine. All except
Lebanon, Libya and Montenegro replied to the survey (15/18, 83%).
3.1. Regulations/Procedures Supporting Immunization of Newly Arrived Migrants
Four countries (Albania, Israel, Palestine and Serbia) reported having regulations/procedures
supporting immunization of newly arrived migrants at the national level. Additionally, in Israel,
provisions for specific population groups are in place: for Ethiopian Jews and undocumented migrants
aged 0–14 years coming from the horn of Africa and for undocumented migrants aged 0–17 years held
in detention facilities.
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Three other countries reported regulations only for specific population groups. Recommendations
exist in Georgia for people coming from Nigeria, Pakistan, Afghanistan and Syria, in Jordan for Syrian
refugees and in Armenia for identifying undocumented migrants, through door to door visits twice
a year (Table 1).
In Algeria, specific regulations/procedures supporting immunization of newly arrived migrants
are in place only in the southern border regions, where migration centres are more concentrated.
In these centres, migrants systematically receive medical attention, care and immunization.
Six countries (Bosnia and Herzegovina, Egypt, Moldova, Republic of Macedonia-FYROM,
Tunisia and Ukraine) reported not having specific regulations/procedures for the immunization of
newly arrived migrants. Kosovo stated that, according to the plan prepared by the Ministry of Health
in case of a migration influx, immunization priority would be given to the vaccination of children aged
less than 5 years against measles and poliomyelitis, in agreement with WHO policy. Egypt, Moldova,
the Republic of Macedonia-FYROM and Tunisia, while reporting no specific regulations/procedures
targeting newly arrived migrants, provided information on vaccinations offered to this population
group, as summarized in Tables 2 and 3.
Table 1. Availability of specific regulations/procedures supporting immunization of newly arrived
migrants in countries from Mediterranean Area and Black Sea Basin (N = 15).
Availability of Regulations/Procedures for
Immunization of Newly Arrived Migrants Number of Countries (n/N) %
1
No regulations/procedures 6/15 40
Regulations/procedures at the national level 4/15 27
Regulations/procedures in some geographical areas 1/15 7
Regulations/procedures for certain population groups 4/15 27
Other 2 1/15 7
1 The sum of percentage exceeds 100% because one country (Israel) reported regulations/procedures at the national
level as well as provisions for specific population groups. 2 Kosovo stated that according to the plan prepared
by Ministry of Health in case of a migration influx, immunization priority would be given to the vaccination of
children aged less than 5 years against measles and poliomyelitis.
3.2. Verification of Immunization Status of Newly Arrived Migrants
The following descriptive analysis on the verification of migrants’ immunization status,
vaccinations offered to newly arrived migrants, target groups, sites for vaccination delivery,
and recording of information on administered vaccines (Table 2) is based on eleven responding
countries. Four countries (Algeria, Bosnia and Herzegovina, Kosovo and Ukraine) did not provide
this information.
Three countries (Armenia, Moldova and Palestine) routinely verify the immunization status of all
newly arrived migrants. Three countries reported verifying immunization status only among specific
population groups: children arriving from countries endemic for tuberculosis or meningitis in Israel,
and students coming from certain African countries in Tunisia. Finally, in Georgia, people coming
from Nigeria, Syria, Afghanistan and Pakistan are assessed for poliomyelitis immunity.
Immunization status is generally verified through anamnesis and verification of the individual
vaccination card. Only Moldova reported using serological testing for hepatitis B, measles,
rubella diphtheria and tetanus.
Four countries (Albania, Jordan, Republic of Macedonia-FYROM and Serbia) do not routinely
verify the immunization status of newly arrived migrants (Table 2, Section 1).
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Table 2. Verification of immunization status of newly arrived migrants, vaccinations offered, target
groups, sites of vaccination delivery and registration of data on administered vaccines in countries
from Mediterranean Area and Black Sea Basin (N = 11).
Characteristics of Vaccination Offer to Newly Arrived Migrants Number of Countries (n/N) 1 %
1. Verification of migrants‘ immunization status
Immunization status routinely verified 3/10 30
Immunization status verified only among specific population groups 3/10 30
Immunization status not routinely verified 4/10 40
2. Target age groups for vaccination offer to newly arrived migrants
Only children 1/11 9
Children and adolescents 2/11 18
Children, adolescents and adults 8/11 73
3. Childhood vaccinations offered to migrants
All the vaccinations included in the National Immunization Plan 8/11 73
Only certain vaccinations are offered to migrants 3/11 27
4. Sites for vaccination delivery
Entry level 2/10 20
Entry and community level 1/10 10
Holding centres and community level 4/10 40
Community level 3/10 30
5. Recording of data on administered vaccines
Individual immunization card is given to migrants and data are recorded
in a registry 7/10 70
An individual immunization card is given to migrants 1/10 10
Data are registered in a paper and/or electronic registry 2/10 20
1 Information on verification of immunization status, sites for vaccination delivery and registration of data on
administered vaccines was provided by 10/11 countries.
3.3. Target Groups and Vaccinations Offered to Newly Arrived Migrants
Concerning the target age groups for vaccination offers among newly arrived migrants (Table 2,
Sections 2 and 3), 8 countries (Albania, Armenia, Egypt, Israel, Jordan, Moldavia, Palestine, Tunisia)
reported offering all the vaccinations included in their National Immunization Plan (NIP) to newly
arrived migrant children. In Egypt, children below 2 years of age are vaccinated according to the
Egyptian national schedule and children under 4 years receive all missed doses according to the
national schedule. In addition, an extra dose of bivalent oral poliomyelitis vaccine (bOPV) is offered
to children of any age (as well as to adolescents and adults) coming from any country declared to
have a polio epidemic according to the latest updated report of the international health emergency
committee (according to International Health Regulations 2005) [37]. An extra bOPV dose is also
offered to children who have no proof of vaccination in the previous 12 months. In Israel, in addition
to routine vaccinations given to all other migrant children, migrants from the horn of Africa are offered
meningococcal and Bacillus Calmette-Guerin (BCG) vaccines.
Three countries reported offering the following selected vaccinations to newly arrived migrants:
Georgia offers poliomyelitis vaccine to people arriving from Nigeria, Pakistan, Afghanistan and
Syria; Republic of Macedonia-FYROM offers poliomyelitis and MMR vaccines; and Serbia offers
poliomyelitis, MMR and diphtheria-tetanus-pertussis (DTP) vaccines (Table 3).
Most countries also offer immunization to adolescent and adult migrants (10 and 8 respectively),
mainly focusing on MMR, diphtheria-tetanus (dT) and/or poliomyelitis vaccination, as described in
Table 3.
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Table 3. Vaccinations offered to newly arrived migrants by age group (children, adolescents and adults)
and site for vaccination delivery, in countries from Mediterranean Area and Black Sea Basin.
Country Children Adolescent Adult Site for VaccineDelivery
Albania All vaccinationsaccording to the NIP 1
dT, poliomyelitis,
MMR
dT, poliomyelitis,
MMR
Detention centres;
community level
Armenia All vaccinationsaccording to the NIP
dT, MMR,
poliomyelitis dT, MMR Community level
Egypt
All vaccinations
according to the NIP for
children less than 4 years
Poliomyelitis vaccine to
children at any age
coming from a country
at polio risk
Poliomyelitis vaccine
to arrivals from
a country at polio risk
Poliomyelitis
vaccine to arrivals
from a country at
polio risk
Community level;
Poliomyelitis
vaccination at
entry level
Georgia
Poliomyelitis vaccine to
arrivals from Nigeria,
Syria, Afghanistan
and Pakistan
Poliomyelitis vaccine
to arrivals from
Nigeria, Syria,
Afghanistan
and Pakistan
Poliomyelitis
vaccine to arrivals
from Nigeria, Syria,
Afghanistan
and Pakistan
Entry level in airports
and seaports
Israel
All vaccinations
according to the NIP;
Meningococcal and BCG
vaccine to arrivals from
Horn of Africa (BCG to
children <4 years)
All vaccinations
according to the NIP to
adolescents aged
11–14 years;
Poliomyelitis vaccine
to adolescents aged
11–17 years;
Meningococcal vaccine
to arrivals from Horn
of Africa
Meningococcal
vaccine to arrivals
from Horn of
Africa; vaccination
in case of outbreaks
Community level;
Meningococcal vaccine
for Ethiopian Jews at
public health clinics set
in Ethiopia by
Israeli government
Jordan
All vaccinations
according to the NIP,
specially for
Syrian refugees
Measles to adolescents
aged 11–15 years
Tetanus to child
bearing age
females (15–49
years) according
to NIP
Community level;
Measles vaccine to
people 6 months–15
years and poliomyelitis
vaccine to children
<5 years also in
holding centres
Moldova All vaccinationsaccording to the NIP
All vaccinations
according to the NIP
All vaccinations
according to the
NIP (hepatitis B
vaccine to risk
groups)
Community level;
Poliomyelitis, DTP,
MR, pneumococcal
vaccine also in
holding centres
Palestine All vaccinationsaccording to the NIP Community level
Republic of
Macedonia-FYROM
Poliomyelitis and MMR
vaccine
Poliomyelitis and
MMR vaccine
Entry level in two
transit centres
Serbia Poliomyelitis, DTP,MMR vaccine
Poliomyelitis, DTP,
MMR vaccine
Tetanus according
to NIP Community level
Tunisia
All vaccinations
according to the NIP,
with particular attention
to Libyan and
Syrian foreigners
Poliomyelitis, DTP,
MMR vaccine
1 NIP: National Immunization Plan.
3.4. Sites for Vaccination Delivery to Newly Arrived Migrants
As shown in Table 2 Section 4, vaccinations are provided at community level in Armenia,
Palestine and Serbia. In Albania, Israel, Jordan and Moldavia, migrants mainly receive vaccinations
at community level; however, priority vaccines are also offered at holding centre level. Israel has
also established pre-entry immunization programmes in public health clinics in Ethiopia targeting
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Jews travelling to Israel and offering meningococcal vaccine before leaving the country. In Egypt,
childhood vaccinations are given at community level, while the extra-dose of bOPV vaccine is
administered within the entry site (Table 3).
In the remaining two countries, vaccinations are administered to newly arrived migrants only at
entry level. Georgia offers oral poliomyelitis vaccine (OPV) to people arriving from at-risk territories
(Nigeria, Syria, Afghanistan and Pakistan) within vaccination service points in airports and seaports.
The Republic of Macedonia-FYROM offers MMR and poliomyelitis vaccine at entry level, in two transit
centres set at both borders. During 2015, migrants in the Republic of Macedonia-FYROM stayed on
average 48 h or less before transiting through the country.
3.5. Recording of Data on Vaccines Administered to Newly Arrived Migrants
In most countries (Albania, Armenia, Georgia, Israel, Jordan, Moldova, Palestine), migrants
receive an immunization card. Data on the administered vaccines are recorded in a paper and/or
electronic registry (Table 2, Section 5). In Georgia, all persons who receive poliomyelitis vaccine at
airport/seaport medical service points receive an immunization card. This data are not entered in
the vaccination registry for the general population; however, monthly reports on all administered
immunizations are sent and collected at the national level. Cases of refusal are promptly reported to
the National Center for Disease Control and Public Health.
In Serbia, only an immunization card is provided to migrants. Instead, in Egypt and Republic of
Macedonia-FYROM data on any administered vaccines are entered in an immunization registry.
4. Discussion
Information on vaccination strategies targeting migrants across the Mediterranean migration
system is limited. The Promovax project (2010–2013) recorded existing migrant immunization policies,
legislation, and practices in selected EU countries (Germany, Norway, Italy, Poland, Greece, Hungary,
Croatia and Cyprus) [38] and analyzed several factors that may influence immunization acceptance
in a list of 10 selected migrant ethnicities [39]. However, the project focussed only on regular
migrants regardless of the length of stay in the country. In 2015, the European Centre for Disease
Prevention and Control (ECDC) collected some information on vaccinations offered to irregular
migrants and asylum seekers from EU/EEA countries [40]. An ongoing study of the EU-funded
CARE project (“Common Approach for REfugees and other migrants’ health”) [41] is also addressing
vaccination strategies; its focus is specifically on six EU countries (Croatia, Greece, Italy, Slovenia,
Malta, and Portugal).
To our knowledge, this is the first study performed to explore immunization strategies targeting
specifically newly arrived migrants with a focus on non EU-countries of the Mediterranean Area and
the Black Sea basin.
We found that, in the majority of the countries we studied, strategies for immunizing newly
arrived migrants are in place. Strategies vary largely according to the organization of the health systems,
the geographic area and neighbouring countries, migration flows and the pattern of immigration.
Notwithstanding, all countries target children who are generally offered all the vaccinations included
in the NIP of the hosting country. Although the number of doses and schedules vary among countries,
all of them have a NIP and consolidated childhood vaccination programmes against poliomyelitis,
measles, rubella, diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B. Most of
them also offer BCG vaccine. About half of the surveyed countries immunize children against
pneumococcus and rotavirus. Israel offers vaccinations also against varicella and hepatitis A [42].
Offering all vaccinations included in the NIP allows them to protect all unimmunized children
(and those with unknown immunization status) as soon as possible. Migrants, in fact, often come
from countries where civil unrest and wars have damaged health services and interrupted vaccination
programmes and might have been unable to initiate or conclude the immunization series.
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Some of the surveyed countries have also extended their vaccination offer to adolescent and adult
migrants. In this case, as per WHO-UNHCR-UNICEF joint recommendations [12], priority is given
to vaccinations against poliomyelitis, measles and rubella, diseases targeted for elimination [43,44].
We found that only half of the surveyed countries have included adults as a target group for migrant
immunization and a survey conducted in 2009 [28] found that adult migrants have more limited access
to free-of charge services. This finding needs to be put in context by specifying that, in EU [45] and
non-EU countries [42], immunization programmes targeting the adult resident population are also
generally less consolidated, if compared to childhood immunization programmes.
Recommendations in place in the Mediterranean Area and the Black Sea show some similarities
with those existing in EU/EEA countries. Of the 17 EU/EEA countries that replied to the 2015
ECDC request, 12 reported offering children all age-appropriate vaccinations as per their NIP,
two countries gave priority to certain vaccines (mainly polio and MMR) and three countries reported
not offering vaccinations yet although the item was under discussion at the time of the ECDC
request (September 2015) [40]. A lower proportion of responding EU/EEA countries (5/17) reported
including also adult migrants in their vaccination offer that mainly included MMR, a diphtheria-tetanus
booster and inactivated polio vaccine (IPV) for asylum seekers from polio-risk areas, according to
WHO-UNHCR-UNICEF joint guidance [12] and ECDC indications [2,46].
In our survey, we also explored sites for vaccination delivery. While the WHO-UNHCR-UNICEF
recommendations state that refugees, asylum seekers and migrants should be immunized without
delay, they do not recommend immunization at border crossings unless there is an outbreak of
a VPD in the host or transit country [12]. In line with these indications, vaccinations are delivered at
community level in most of the countries we studied. Many vaccines require two or three doses at
timed intervals and the follow up of the full immunization series. Starting/updating vaccinations
after the integration of migrants, through the same health services used by the local population,
might facilitate the administration of full vaccination cycles by planning and respecting scheduled
time intervals. On the other side, barriers in accessing community health services might unnecessarily
delay the administration of first doses, especially while people are on the move.
This finding is in line with the 2009 survey mentioned above [28] that found that the predominant
vaccination delivery pattern for migrants was through community-based services also targeting
the general population in EU and non EU countries of the Mediterranean basin. The authors
commented that, although in principle migrant populations were reported as eligible for these services,
informal barriers (linguistic, cultural, etc.) could be fostered due to the lack of migrant sensitive
approaches to service delivery.
In our survey, only a minority of countries provide vaccinations at the entry level, confirming
a mainly community-based service delivery model: in Georgia polio vaccine is given to people coming
from high-risk countries and in Republic of Macedonia-FYROM only poliomyelitis and MMR vaccines
are provided. Egypt delivers all childhood vaccinations at the community level, while the extra-dose
of polio vaccine is offered at entry point to migrants coming from countries declared at risk for
poliomyelitis. In this case, the migrants' entrance in the country is used to promptly provide one shot
of the priority vaccines as soon as possible, in order not to lose them after their entry in the country.
The WHO-UNHCR-UNICEF guidance also suggests providing documentation of each
administered vaccination to the concerned migrant or child’s caregiver to help avoid unnecessary
re-vaccinations [12]. In most of the countries that replied to our questionnaire, an individual vaccination
card is delivered to migrants and data are entered in electronic or paper immunization registries.
However, individual cards are possibly lost during the long journey or destroyed on purpose to
eliminate any document that could allow the migrant’s identification for the fear of legal consequences.
Furthermore, countries where information on administered doses is archived in national databases
might not routinely share their data with other countries. Procedures to keep track of migrants’
immunization data across countries should be improved to avoid lack or duplication of vaccination.
This is a challenge as it entails a very strict coordination and collaboration among public health
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authorities of different countries to define a common format for data sharing and sophisticated
infrastructures to exchange electronic data while ensuring confidentiality.
Some pilot projects are ongoing to track the health status of migrants and refugees in order to
facilitate follow up and continuity of care. The International Organization for Migration, with the
support from the European Commission, is developing and piloting an online health platform (E-PHR,
Electronic Personal Health Record) to archive migrants’ health information and to ensure that migrant
health assessment records are available, under strict data protection rules, at transit and destination
countries [47,48]. Concomitantly, a paper format of the Personal Health Record (PHR), was produced.
This document is designed to be compiled by healthcare workers after clinical consultations and
left with the consulted migrant/refugee who can then show it to the healthcare workers he/she
may subsequently encounter during the journey [47]. Building upon the PHR, the CARE project
is developing an integrated electronic system that encompasses a portable device to be delivered
to migrants and refugees, containing their personal medical history, as well as information on any
treatment provided [49].
Our survey has certain limitations. As the questionnaire was filled by an expert at the national
level, we collected information on national immunization strategies targeting newly arrived migrants
but could not investigate how those strategies are implemented at the local level. Moreover, as this
study was conducted as part of a wider survey, it was not possible to introduce more detailed questions
in order not to overload the countries’ experts in charge of filling the questionnaire, thus improving
the participation rate. For this reason, we could not investigate if variability at sub-national level
exists and how vaccinations are accepted by migrants. Access of migrants to centre/community health
services, vaccination coverage and proportion of completed cycles were also not assessed.
Another limitation is that we used a broad definition of “migrant”, that includes diverse
population groups (such as refugees and asylum seekers, undocumented migrants, economic migrants,
students) with different legal status and, consequently, possibly different access to vaccination. We were
therefore unable to explore how immunization offers vary across these different groups.
Finally, given the short format of the survey, a higher number of piloting countries would have
reduced the risk of bias in the interpretation of the questions.
5. Conclusions
This study provides a first overview of current immunization strategies targeting newly arrived
migrants in non EU-countries of the Mediterranean Area and the Black Sea basin. Although diversified,
implementation strategies for immunizing newly arrived migrants are in place in most of the surveyed
countries, mainly targeting unvaccinated children or those with an unknown immunization status.
Migrants are considered a vulnerable group for certain infectious diseases because they can
originate from disease-endemic countries and because they can be exposed to poor living conditions
and overcrowding during their arduous journeys. Their desired destinations are countries with
decreasing immunization coverage levels and pockets of susceptible populations. As migratory
pressure is increasing population movements across borders, all countries should play their role
in identifying unprotected people (or those with unknown immunization status) and ensure
the implementation of appropriate immunization programmes for refugees, asylum seekers and
migrants [50]. Vaccination, in fact, represents a tool for the greater benefit of all, protecting both the
health of migrants and of the host community. For this reason, immunization offers to migrants should
be regulated and guaranteed in all countries and acceptance should be monitored.
Our study highlighted a widespread immunization offer to migrant children according to the
NIPs. However, from our results, we cannot infer how existing strategies are implemented at the local
level, whether they are currently functioning and whether, and what, barriers to their implementation
are being faced. Further studies focusing on these aspects are needed to develop concrete and targeted
recommendations for action. In addition, a more focused study aiming to assess immunization
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entitlement gaps among less targeted population groups, such as adults and/or more disadvantaged
migratory status groups, such as irregular migrants, is needed.
At the same time, more efforts such as development of online immunization registries and the
promotion of cooperation between countries of origin, transit and destination, should be encouraged
in order to share immunization strategies and monitor administered vaccines. The finalization,
sharing and dissemination of the pilot projects mentioned above [47–49] could represent useful steps
to track the health status of migrants and refugees, establishing mechanisms of collaboration among
countries. This could guarantee appropriate and targeted health assistance for migrants/refugees and
facilitate cross-border immunization planning. Furthermore, effective health status monitoring can
also lead to avoiding unnecessary health actions, including unnecessary re-vaccination.
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